SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000912282-17-000044
Filing Date
2017-02-13
Accepted
2017-02-13 14:15:08
Documents
2
Group Members
PUBLIC JOINT STOCK CO PHARMSTANDARD

Document Format Files

Seq Description Document Type Size
1 pharm-protag13g_021017.htm SC 13G 84061
2 JOINT FILING AGREEMENT ex99_1.htm EX-99.1 5226
  Complete submission text file 0000912282-17-000044.txt   90993
Mailing Address 521 COTTONWOOD DRIVE, SUITE 100 MALPITAS CA 95035-7404
Business Address 521 COTTONWOOD DRIVE, SUITE 100 MALPITAS CA 95035-7404 408-649-7370
Protagonist Therapeutics, Inc (Subject) CIK: 0001377121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89601 | Film No.: 17598087
SIC: 2834 Pharmaceutical Preparations

Mailing Address 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE LUXEMBOURG N4 L-1528
Business Address 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE LUXEMBOURG N4 L-1528 352 26449 557
Pharmstandard International S.A. (Filed by) CIK: 0001598762 (see all company filings)

IRS No.: 000000000
Type: SC 13G